Company Overview of NKT Therapeutics, Inc.
NKT Therapeutics, Inc., a biotechnology company, engages in developing therapeutics based on immune cells called natural killer T cells (NKT). It focuses to develop a pipeline of NKT based therapeutics to treat cancer, infectious diseases, autoimmune diseases, asthma, and atopic dermatitis. The company was incorporated in 2008 and is based in Waltham, Massachusetts.
1000 Winter Street
Waltham, MA 02451
Founded in 2008
Key Executives for NKT Therapeutics, Inc.
NKT Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Therapeutic Peptides, Inc.||United States|
|GlycoFi, Inc.||United States|
|TNI Pharmaceuticals, Inc.||United States|
|Centrillion Technology Holdings Corporation||United States|
|ProChon Biotech Ltd.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact NKT Therapeutics, Inc., please visit www.nktrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.